Predictive Utility of the Vedolizumab Clinical Decision Support Tool in a Real-World IBD Cohort: Differential Performance in Crohn’s Disease and Ulcerative Colitis
<i>Background and Objectives</i><i>:</i> The vedolizumab clinical decision support tool (VDZ-CDST) was developed to predict treatment outcomes in inflammatory bowel disease (IBD). While validated in clinical trial and consortium settings, its real-world performance remains less clear. The aim of our...
Sparad:
| Huvudupphov: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
MDPI AG
2026-04-01
|
| Serie: | Medicina |
| Ämnen: | |
| Länkar: | https://www.mdpi.com/1648-9144/62/4/722 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|